Host basophils are dispensable for induction of donor T helper 2 cell differentiation and severity of experimental graft-versus-host disease

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 12, 2011, Pages 1747-1753

  Tawara, Isao ^a   Nieves, Evelyn ^a   Liu, Chen ^b   Evers, Rebecca ^a   Toubai, Tomomi ^a   Sun, Yaping ^a   Alrubaie, Mariem ^a   Reddy, Pavan ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Antigen presenting cell; Graft versus host disease; Th2 polarization

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 5; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; BASOPHIL; BONE MARROW TRANSPLANTATION; CELL POLARITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GRAFT VERSUS HOST REACTION; HOST CELL; IMMUNE RESPONSE; IMMUNOREGULATION; LYMPHOCYTE DIFFERENTIATION; MORTALITY; MOUSE; NONHUMAN; TH1 TH2 BALANCE; TH2 CELL;

ANIMALS; ANTIGEN-PRESENTING CELLS; BASOPHILS; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; FEMALE; GRAFT VS HOST DISEASE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; TH2 CELLS;

EID: 81255197715     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2011.08.013     Document Type: Article

References (41)

1. Min B. Basophils: what they "can do" versus what they "actually do" Nat Immunol 2008, 9:1333-1339.
2. Arinobu Y., Iwasaki H., Gurish M.F., et al. Developmental checkpoints of the basophil/mast cell lineages in adult murine hematopoiesis. Proc Natl Acad Sci USA 2005, 102:18105-18110.
3. Karasuyama H., Mukai K., Obata K., et al. Nonredundant roles of basophils in immunity. Annu Rev Immunol 2011, 29:45-69.
4. Sokol C.L., Medzhitov R. Role of basophils in the initiation of Th2 responses. Curr Opin Immunol 2010, 22:73-77.
5. Oh K., Shen T., Le Gros G., et al. Induction of Th2 type immunity in a mouse system reveals a novel immunoregulatory role of basophils. Blood 2007, 109:2921-2927.
6. Min B., Prout M., Hu-Li J., et al. Basophils produce IL-4 and accumulate in tissues after infection with a Th2-inducing parasite. J Exp Med 2004, 200:507-517.
7. Sokol C.L., Barton G.M., Farr A.G., et al. A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat Immunol 2008, 9:310-318.
8. Sokol C.L., Chu N.Q., Yu S., et al. Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response. Nat Immunol 2009, 10:713-720.
9. Mack M., Schneider M.A., Moll C., et al. Identification of antigen-capturing cells as basophils. J Immunol 2005, 174:735-741.
10. + T cell interactions promote T(H)2 cytokine-dependent immunity. Nat Immunol 2009, 10:697-705.
11. + T cells. Nat Immunol 2009, 10:706-712.
12. Sullivan B.M., Liang H.E., Bando J.K., et al. Genetic analysis of basophil function in vivo. Nat Immunol 2011, 12:527-535.
13. Ohnmacht C., Schwartz C., Panzer M., et al. Basophils orchestrate chronic allergic dermatitis and protective immunity against helminths. Immunity 2010, 33:364-374.
14. Hammad H., Plantinga M., Deswarte K., et al. Inflammatory dendritic cells-not basophils-are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen. J Exp Med 2010, 207:2097-2111.
15. Tang H., Cao W., Kasturi S.P., et al. The T helper type 2 response to cysteine proteases requires dendritic cell-basophil cooperation via ROS-mediated signaling. Nat Immunol 2010, 11:608-617.
16. Phythian-Adams A.T., Cook P.C., Lundie R.J., et al. CD11c depletion severely disrupts Th2 induction and development in vivo. J Exp Med 2010, 207:2089-2096.
17. Welniak L.A., Blazar B.R., Murphy W.J. Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu Rev Immunol 2007, 25:139-170.
18. Paczesny S., Hanauer D., Sun Y., et al. New perspectives on the biology of acute GVHD. Bone Marrow Transplant 2009, 45:1-11.
19. Tawara I., Maeda Y., Sun Y., et al. Combined Th2 cytokine deficiency in donor T cells aggravates experimental acute graft-vs-host disease. Exp Hematol 2008, 36:988-996.
20. Murphy W.J., Welniak L.A., Taub D.D., et al. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice. J Clin Invest 1998, 102:1742-1748.
21. Nikolic B., Lee S., Bronson R.T., et al. Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets. J Clin Invest 2000, 105:1289-1298.
22. Shlomchik W.D. Graft-versus-host disease. Nat Rev Immunol 2007, 7:340-352.
23. + dendritic cells reduces experimental acute GVHD in an IL-10-dependent manner. Blood 2010, 115:724-735.
24. Tawara I., Koyama M., Liu C., et al. Interleukin-6 modulates graft-versus-host responses after experimental allogeneic bone marrow transplantation. Clin Cancer Res 2011, 17:77-88.
25. Lee J.J., McGarry M.P. When is a mouse basophil not a basophil?. Blood 2007, 109:859-861.
26. Reddy P., Sun Y., Toubai T., et al. Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice. J Clin Invest 2008, 118:2562-2573.
27. Reddy P., Maeda Y., Hotary K., et al. Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect. Proc Natl Acad Sci USA 2004, 101:3921-3926.
28. Hill G.R., Crawford J.M., Cooke K.R., et al. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 1997, 90:3204-3213.
29. Reddy P., Negrin R., Hill G.R. Mouse models of bone marrow transplantation. Biol Blood Marrow Transplant 2008, 14:129-135.
30. Shlomchik W.D., Couzens M.S., Tang C.B., et al. Prevention of graft-versus-host disease by inactivation of host antigen-presenting cells. Science 1999, 285:412-415.
31. Teshima T., Ordemann R., Reddy P., et al. Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat Med 2002, 8:575-581.
32. Reddy P., Maeda Y., Liu C., et al. A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses. Nat Med 2005, 11:1244-1249.
33. Denzel A., Maus U.A., Rodriguez Gomez M., et al. Basophils enhance immunological memory responses. Nat Immunol 2008, 9:733-742.
34. MacDonald K.P., Palmer J.S., Cronau S., et al. An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation. Blood 2010, 116:3955-3963.
35. Matte C.C., Liu J., Cormier J., et al. Donor APCs are required for maximal GVHD but not for GVL. Nat Med 2004, 10:987-992.
36. Kaplan D.H., Anderson B.E., McNiff J.M., et al. Target antigens determine graft-versus-host disease phenotype. J Immunol 2004, 173:5467-5475.
37. Duffner U.A., Maeda Y., Cooke K.R., et al. Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease. J Immunol 2004, 172:7393-7398.
38. Markey K.A., Banovic T., Kuns R.D., et al. Conventional dendritic cells are the critical donor APC-presenting alloantigen after experimental bone marrow transplantation. Blood 2009, 113:5644-5649.
39. Rowe V., Banovic T., MacDonald K.P., et al. Host B cells produce IL-10 following TBI and attenuate acute GVHD after allogeneic bone marrow transplantation. Blood 2006, 108:2485-2492.
40. Matte-Martone C., Wang X., Anderson B., et al. Recipient B cells are not required for graft-versus-host disease induction. Biol Blood Marrow Transplant 2010, 16:1222-1230.
41. Murphy G.F., Sueki H., Teuscher C., et al. Role of mast cells in early epithelial target cell injury in experimental acute graft-vs-host disease. J Invest Dermatol 1994, 102:451-461.